{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T07:42:34Z","timestamp":1782978154111,"version":"3.54.5"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"name":"Vice Chancellor for Research and Technology, Rafsanjan University of Medical Sciences"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.lfs.2020.117450","type":"journal-article","created":{"date-parts":[[2020,2,20]],"date-time":"2020-02-20T07:47:13Z","timestamp":1582184833000},"page":"117450","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Whole body hypothermia extends tissue plasminogen activator treatment window in the rat model of embolic stroke"],"prefix":"10.1016","volume":"256","author":[{"given":"Mahsa","family":"Hassanipour","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammadreza","family":"Zarisfi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vahid","family":"Ehsani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Allahtavakoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.lfs.2020.117450_bb0005","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.pbb.2007.04.015","article-title":"Acute ischemic stroke: overview of major experimental rodent models, pathophysiology, and therapy of focal cerebral ischemia","volume":"87","author":"Durukan","year":"2007","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"12","key":"10.1016\/j.lfs.2020.117450_bb0010","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.1161\/01.STR.31.12.2920","article-title":"Intravenous tissue plasminogen activator for acute ischemic stroke","volume":"31","author":"Chapman","year":"2000","journal-title":"Stroke"},{"issue":"3","key":"10.1016\/j.lfs.2020.117450_bb0015","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/cpt.33","article-title":"Recombinant tissue plasminogen activators (rtPA): a review","volume":"97","author":"Gurman","year":"2015","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.lfs.2020.117450_bb0020","unstructured":"A. Qureshi, R. Pande, S. Kim, R. Hanel, J. Kirmani, A. Yahia, Third generation thrombolytics for the treatment of ischemic stroke, Current opinion in investigational drugs (London, England: 2000) 3(12) (2002) 1729-1732."},{"key":"10.1016\/j.lfs.2020.117450_bb0025","doi-asserted-by":"crossref","unstructured":"C.R. Carpenter, S.M. Keim, W.K. Milne, W.J. Meurer, W.G. Barsan, B.E.i.E.M.I. Group, Thrombolytic therapy for acute ischemic stroke beyond three hours, The Journal of emergency medicine 40(1) (2011) 82\u201392.","DOI":"10.1016\/j.jemermed.2010.05.009"},{"key":"10.1016\/j.lfs.2020.117450_bb0030","doi-asserted-by":"crossref","unstructured":"I. dela Pe\u00f1a, C. Borlongan, G. Shen, W. Davis, Strategies to extend thrombolytic time window for ischemic stroke treatment: an unmet clinical need, Journal of stroke 19(1) (2017) 50.","DOI":"10.5853\/jos.2016.01515"},{"issue":"3","key":"10.1016\/j.lfs.2020.117450_bb0035","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1161\/STR.0b013e318284056a","article-title":"Guidelines for the early management of patients with acute ischemic stroke","volume":"44","author":"Jauch","year":"2013","journal-title":"Stroke"},{"issue":"5","key":"10.1016\/j.lfs.2020.117450_bb0040","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/bcpt.12413","article-title":"Ascorbic acid reduces the adverse effects of delayed administration of tissue plasminogen activator in a rat stroke model","volume":"117","author":"Allahtavakoli","year":"2015","journal-title":"Basic & clinical pharmacology & toxicology"},{"issue":"10","key":"10.1016\/j.lfs.2020.117450_bb0045","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1161\/STROKEAHA.110.592295","article-title":"Intravenous thrombolysis plus hypothermia for acute treatment of ischemic stroke (ICTuS-L)","volume":"41","author":"Hemmen","year":"2010","journal-title":"Stroke"},{"issue":"1","key":"10.1016\/j.lfs.2020.117450_bb0050","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1161\/STROKEAHA.113.003143","article-title":"Therapeutic hypothermia after recanalization in patients with acute ischemic stroke","volume":"45","author":"Hong","year":"2014","journal-title":"Stroke"},{"issue":"9","key":"10.1016\/j.lfs.2020.117450_bb0055","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1161\/01.STR.0000088062.86084.F2","article-title":"Profiles of matrix metalloproteinases, their inhibitors, and laminin in stroke patients","volume":"34","author":"Horstmann","year":"2003","journal-title":"Stroke"},{"issue":"2","key":"10.1016\/j.lfs.2020.117450_bb0060","doi-asserted-by":"crossref","first-page":"134","DOI":"10.2174\/1567202611310020006","article-title":"The neurovascular protection afforded by delayed local hypothermia after transient middle cerebral artery occlusion","volume":"10","author":"Kim","year":"2013","journal-title":"Curr. Neurovasc. Res."},{"key":"10.1016\/j.lfs.2020.117450_bb0065","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.brainresbull.2017.07.007","article-title":"Transient brain hypothermia reduces the reperfusion injury of delayed tissue plasminogen activator and extends its therapeutic time window in a focal embolic stroke model","volume":"134","author":"Zarisfi","year":"2017","journal-title":"Brain Res. Bull."},{"issue":"3","key":"10.1016\/j.lfs.2020.117450_bb0070","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S1474-4422(13)70013-9","article-title":"Hypothermia for acute ischaemic stroke","volume":"12","author":"Wu","year":"2013","journal-title":"The Lancet Neurology"},{"issue":"2","key":"10.1016\/j.lfs.2020.117450_bb0075","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/MCC.0000000000000398","article-title":"Is there still a role for hypothermia in neurocritical care?","volume":"23","author":"Frank","year":"2017","journal-title":"Curr. Opin. Crit. Care"},{"issue":"1","key":"10.1016\/j.lfs.2020.117450_bb0080","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/2040-7378-4-3","article-title":"Mild hypothermia of 34 C reduces side effects of rt-PA treatment after thromboembolic stroke in rats","volume":"4","author":"Kallm\u00fcnzer","year":"2012","journal-title":"Experimental & translational stroke medicine"},{"issue":"1","key":"10.1016\/j.lfs.2020.117450_bb0085","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1747-4949.2005.00011.x","article-title":"Therapeutic hypothermia for acute stroke","volume":"1","author":"Lyden","year":"2006","journal-title":"Int. J. Stroke"},{"issue":"1","key":"10.1016\/j.lfs.2020.117450_bb0090","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0006-8993(03)03088-9","article-title":"Topographically graded postischemic presence of metalloproteinases is inhibited by hypothermia","volume":"984","author":"Wagner","year":"2003","journal-title":"Brain Res."},{"issue":"4","key":"10.1016\/j.lfs.2020.117450_bb0095","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1089\/ther.2015.0010","article-title":"Very mild hypothermia (35\u00b0 C) postischemia reduces infarct volume and blood\/brain barrier breakdown following tPA treatment in the mouse","volume":"5","author":"Cechmanek","year":"2015","journal-title":"Therapeutic Hypothermia and Temperature Management"},{"issue":"1","key":"10.1016\/j.lfs.2020.117450_bb0100","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s12035-013-8538-z","article-title":"Mmp-9 inhibition: a therapeutic strategy in ischemic stroke","volume":"49","author":"Chaturvedi","year":"2014","journal-title":"Mol. Neurobiol."},{"issue":"7","key":"10.1016\/j.lfs.2020.117450_bb0105","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1111\/j.1460-9568.2011.07843.x","article-title":"Recombinant tissue plasminogen activator induces blood\u2013brain barrier breakdown by a matrix metalloproteinase-9-independent pathway after transient focal cerebral ischemia in mouse","volume":"34","author":"Copin","year":"2011","journal-title":"Eur. J. Neurosci."},{"issue":"3","key":"10.1016\/j.lfs.2020.117450_bb0110","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.brainresbull.2011.03.019","article-title":"Sigma-1 receptor ligand PRE-084 reduced infarct volume, neurological deficits, pro-inflammatory cytokines and enhanced anti-inflammatory cytokines after embolic stroke in rats","volume":"85","author":"Allahtavakoli","year":"2011","journal-title":"Brain Res. Bull."},{"issue":"10","key":"10.1016\/j.lfs.2020.117450_bb0115","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1161\/01.STR.29.10.2171","article-title":"Optimal depth and duration of mild hypothermia in a focal model of transient cerebral ischemia","volume":"29","author":"Maier","year":"1998","journal-title":"Stroke"},{"issue":"2","key":"10.1016\/j.lfs.2020.117450_bb0120","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1089\/ther.2013.0010","article-title":"Mild hypothermia reduces tissue plasminogen activator-related hemorrhage and blood brain barrier disruption after experimental stroke","volume":"3","author":"Tang","year":"2013","journal-title":"Therapeutic hypothermia and temperature management"},{"issue":"4","key":"10.1016\/j.lfs.2020.117450_bb0125","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1161\/01.STR.0000206281.77178.ac","article-title":"Microglia potentiate damage to blood\u2013brain barrier constituents","volume":"37","author":"Yenari","year":"2006","journal-title":"Stroke"},{"key":"10.1016\/j.lfs.2020.117450_bb0130","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ejphar.2015.06.043","article-title":"Opening the window: ischemic postconditioning reduces the hyperemic response of delayed tissue plasminogen activator and extends its therapeutic time window in an embolic stroke model","volume":"764","author":"Esmaeeli-Nadimi","year":"2015","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.lfs.2020.117450_bb0135","article-title":"Therapeutic hypothermia protects in vitro brain barrier from ischaemic damage through attenuation of inflammatory cytokine release and apoptosis","volume":"2","author":"Mathur","year":"2017","journal-title":"Stroke Research & Therapy"},{"key":"10.1016\/j.lfs.2020.117450_bb0140","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.expneurol.2015.06.006","article-title":"Therapeutic hypothermia for stroke: where to go?","volume":"272","author":"Han","year":"2015","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.lfs.2020.117450_bb0145","doi-asserted-by":"crossref","first-page":"415","DOI":"10.3389\/fncel.2015.00415","article-title":"Impacts of tissue-type plasminogen activator (tPA) on neuronal survival","volume":"9","author":"Chevilley","year":"2015","journal-title":"Front. Cell. Neurosci."},{"issue":"1","key":"10.1016\/j.lfs.2020.117450_bb0150","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jns.2014.09.036","article-title":"Effects of tissue plasminogen activator timing on blood\u2013brain barrier permeability and hemorrhagic transformation in rats with transient ischemic stroke","volume":"347","author":"Zhang","year":"2014","journal-title":"J. Neurol. Sci."},{"issue":"4","key":"10.1016\/j.lfs.2020.117450_bb0155","doi-asserted-by":"crossref","first-page":"615","DOI":"10.2334\/josnusd.51.615","article-title":"Measurement of cerebral reactive hyperemia at the initial post-ischemia reperfusion stage under normothermia and moderate hypothermia in rats","volume":"51","author":"Kunimatsu","year":"2009","journal-title":"J. Oral Sci."},{"key":"10.1016\/j.lfs.2020.117450_bb0160","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.brainres.2016.05.042","article-title":"Hypothermia-induced ischemic tolerance is associated with Drp1 inhibition in cerebral ischemia-reperfusion injury of mice","volume":"1646","author":"Tang","year":"2016","journal-title":"Brain Res."},{"issue":"1","key":"10.1016\/j.lfs.2020.117450_bb0165","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/WCO.0b013e328334da32","article-title":"Reperfusion for acute ischemic stroke: arterial revascularization and collateral therapeutics","volume":"23","author":"Liebeskind","year":"2010","journal-title":"Curr. Opin. Neurol."},{"issue":"3","key":"10.1016\/j.lfs.2020.117450_bb0170","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.cardiores.2005.12.002","article-title":"Structure and function of matrix metalloproteinases and TIMPs","volume":"69","author":"Nagase","year":"2006","journal-title":"Cardiovasc. Res."},{"issue":"2","key":"10.1016\/j.lfs.2020.117450_bb0175","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0166-2236(97)01169-7","article-title":"Matrix metalloproteinases and diseases of the CNS","volume":"21","author":"Yong","year":"1998","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.lfs.2020.117450_bb0180","series-title":"Matrix Metalloproteinases and Blood-brain Barrier Disruption in Acute Ischemic Stroke, Frontiers in Neurology 4","author":"Lakhan","year":"2013"},{"issue":"3","key":"10.1016\/j.lfs.2020.117450_bb0185","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.nbd.2010.03.008","article-title":"Molecular insights and therapeutic targets for blood\u2013brain barrier disruption in ischemic stroke: critical role of matrix metalloproteinases and tissue-type plasminogen activator","volume":"38","author":"Jin","year":"2010","journal-title":"Neurobiol. Dis."},{"issue":"3","key":"10.1016\/j.lfs.2020.117450_bb0190","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1089\/ther.2012.0007","article-title":"Temperature affects thrombolytic efficacy using rt-PA and eptifibatide, an in vitro study","volume":"2","author":"Meunier","year":"2012","journal-title":"Therapeutic hypothermia and temperature management"}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320520301983?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320520301983?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,28]],"date-time":"2024-12-28T19:16:45Z","timestamp":1735413405000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320520301983"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":38,"alternative-id":["S0024320520301983"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2020.117450","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Whole body hypothermia extends tissue plasminogen activator treatment window in the rat model of embolic stroke","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2020.117450","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"117450"}}